Histone mediated transduction for gene therapy and novel reverse transfection cell microarrays based on aminomalononitrile self-polymerisation chemistry
posted on 2017-03-02, 23:49authored byNastasie, Michael
Our understanding of the link between gene function and disease is constantly
strengthening however gene therapy is currently limited by a lack of safe, efficient and
specific vectors for DNA delivery. Histone mediated transduction (HMT) is a promising,
efficient non-viral DNA delivery technique utilising histone proteins as non-toxic DNA
vectors. The tumour cell enhanced nuclear targeting signal (tNTS) of the Apoptin protein has
been fused to histones in Chapter 2 to create novel recombinant histone proteins that
specifically accumulate in the nucleus of cancer cells. Nuclear accumulation was
characterised in a breast tumour progression model, demonstrating that the tNTS has
increased specificity for the latter stages of tumour progression. This study also identified an
affinity of histone proteins for cancer cells, leading to recombinant proteins with a >13-fold
specificity for cancer cell nuclei, with important implications for future cancer specific gene
therapy approaches.
Reverse Transfection Cell Microarray (RTCM) technology is designed for the
simultaneous high throughput analysis of numerous genes in a live cell format and promises
to revolutionise data collection from tissue culture cell lines. RTCM technology however is
limited by inefficient transfection and the lack of a simple, efficient and inexpensive 2D cell
surface patterning system. These surfaces only allow cells to attach to spots containing
arrayed genetic material, facilitating automated analysis and reducing cross-contamination,
thereby enhancing the efficiency of the array.
Chapter 3 addresses the synthesis and optimisation of a novel, inexpensive and simple
2D cell surface patterning system based on aminomalononitrile (AMN) chemistry. An
activated AMN solution was spotted onto a non-fouling (bio-resistant) poly(hydroxyethyl
methacrylate) (pHEMA) background, limiting cell attachment to areas where AMN polymer
is present. Chapter 4 investigates the addition of positively charged copolymers to the
activated AMN and further optimises the transfection solution while chapter 5 investigates
histone octamer and tetramer based reverse transfection on RTCMs for the first time. The
result is a pHEMA-AMN-5% poly(allylamine) 2D patterned surface that is simpler to
produce than any previously described, offering significant advantages over current RTCM
technology. HMT was found to provide a benefit to RTCMs utilising Lipofectamine 2000
transfection, with implications for RTCMs utilising that reagent.
Due to the simplicity and customisability of the AMN chemistry demonstrated, the 2D
surface patterning system generated in this thesis is poised to make a significant contribution
to the high-throughput screening of genetic material, drugs and other biomolecules in live
cells, facilitating the progress of numerous scientific fields.